These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9723326)

  • 1. Clinical impact of Neoral in thoracic organ transplantation.
    Aziz T; el-Gamel A; Keevil B; Krysiak P; Campbell C; Rahman A; Deiraniya A; Yonan N
    Transplant Proc; 1998 Aug; 30(5):1900-3. PubMed ID: 9723326
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
    Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G
    Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
    [No Abstract]   [Full Text] [Related]  

  • 3. Population pharmacokinetics of cyclosporine: influence of covariables and assessment of cyclosporine absorption in kidney, lung, heart and heart + lung transplanted patients.
    Kyhl LE; Rasmussen SN; Aarons L; Jensen SB
    Transplant Proc; 1998 Aug; 30(5):1680. PubMed ID: 9723241
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term safety and efficacy of Neoral in heart transplantation.
    Yonan NA; Aziz T; el-Gamel A; Campbell CS; Rahman AN; Deiraniya AK
    Transplant Proc; 1998 Aug; 30(5):1906-9. PubMed ID: 9723328
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoral conversion in stable thoracic transplant patients leads to dose reduction.
    Zaldonis DB; Keenan RJ; Pham SM; Kormos RL; Griffith BP
    Transplant Proc; 1998 Aug; 30(5):1898-9. PubMed ID: 9723325
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoral conversion in stable thoracic transplant patients leads to dose reduction.
    Zaldonis DB; Keenan RJ; Pham SM; Kormos RL; Griffith BP
    Transplant Proc; 1998 Jun; 30(4):1158-9. PubMed ID: 9636468
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion from standard cyclosporine to Neoral in lung transplant recipients.
    Kesten S; Scavuzzo M; Laurin L; Tan A; Chaparro C
    Transplant Proc; 1998 Aug; 30(5):1895-7. PubMed ID: 9723324
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year.
    Cooney GF; Jeevanandam V; Choudhury S; Feutren G; Mueller EA; Eisen HJ
    Transplant Proc; 1998 Aug; 30(5):1892-4. PubMed ID: 9723323
    [No Abstract]   [Full Text] [Related]  

  • 9. An investigation of the pharmacokinetics, toxicity, and clinical efficacy of Neoral cyclosporin in cystic fibrosis patients.
    Mikhail G; Eadon H; Leaver N; Rogers P; Stephens D; Banner N; Khaghani A; Yacoub M
    Transplant Proc; 1997; 29(1-2):599-601. PubMed ID: 9123148
    [No Abstract]   [Full Text] [Related]  

  • 10. Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter-individual variations in patients affected with cystic fibrosis.
    Girault D; Haloun A; Viard L; Bellon G; Gottrand F; Guillemain R; Lenoir G; Ladurie FL; Plouvier E; Storni V
    Transplant Proc; 1995 Aug; 27(4):2488-90. PubMed ID: 7652899
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoral conversion study: shift from Sandimmune classic formulation to Sandimmune Neoral in heart and lung transplant patients.
    Svendsen U; Larsen K; Allermand H; Thayssen P; Jensen S; Pettersson G
    Transplant Proc; 1995 Dec; 27(6):3477. PubMed ID: 8540057
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
    Schiavelli R; Sgrosso JL; Sabbatiello R; Castro C; Ahualli L; Pattin M; Vazquez MC
    Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Toze CL; Corr T; Currie C; Strong DK; Keown PA
    Transplant Proc; 1998 Aug; 30(5):1668-70. PubMed ID: 9723236
    [No Abstract]   [Full Text] [Related]  

  • 15. The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.
    Wilczek HE; Berglin E; Blohmé I; Bäckman L; Fehrman I; Källen R; Nyberg G; Säwe J; Wahlberg J
    Transplant Proc; 1997; 29(1-2):280-3. PubMed ID: 9122995
    [No Abstract]   [Full Text] [Related]  

  • 16. Changing stable heart transplant recipients from Sandimmune to Neoral.
    Dalrymple-Hay M; Meara M; Reynolds L; Backhouse L; Wright D; Holt D; Johnston A; Madden B; Murday A
    Transplant Proc; 1996 Aug; 28(4):2285-6. PubMed ID: 8769227
    [No Abstract]   [Full Text] [Related]  

  • 17. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
    Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical impact of Neoral in heart transplantation.
    Aziz T; el-Gamel A; Keevil B; Martyszczuk R; Campbell C; Rahman A; Deiraniya A; Yonan N
    Transplant Proc; 1998 Jun; 30(4):1152-3. PubMed ID: 9636466
    [No Abstract]   [Full Text] [Related]  

  • 19. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
    Foradori A; Pinto VM; Elberg A
    Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis.
    Walker S; Habib S; Rose M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1519-20. PubMed ID: 9636618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.